[Problems posed by formulation of dry forms with delayed action administered orally].
作者信息
Delporte J P
出版信息
Farmaco Prat. 1974 Aug;29(8):407-32.
PMID:4849495
Abstract
摘要
相似文献
1
[Problems posed by formulation of dry forms with delayed action administered orally].
Farmaco Prat. 1974 Aug;29(8):407-32.
2
[Effectivness prolongation of drugs with special consideration for peroral depot drug forms].
Pharmazie. 1971 Feb;26(2):57-77.
3
[Development of an oral nitroglycerin proxyphyllin retard compound].
Arzneimittelforschung. 1970 Sep;20(9):1180-7.
4
[Effect of the production process on the quality of drugs].[生产工艺对药品质量的影响]
Farm Zh. 1976 Mar-Apr(2):20-7.
5
Assessment of the feasibility of oral controlled release in an exploratory development setting.在探索性研发环境中评估口服控释的可行性。
Drug Discov Today. 2005 Sep 1;10(17):1159-66. doi: 10.1016/S1359-6446(05)03551-8.
6
The in vitro development of extended-release solid oral dosage forms.
J Pharmacokinet Biopharm. 1985 Oct;13(5):493-514. doi: 10.1007/BF01059332.
7
Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications.基于生物药剂学分类系统的难溶性药物制剂设计：基本方法与实际应用。
Int J Pharm. 2011 Nov 25;420(1):1-10. doi: 10.1016/j.ijpharm.2011.08.032. Epub 2011 Aug 30.
8
Biorelevant in-vitro performance testing of orally administered dosage forms.口服给药制剂的生物相关性体外性能测试。
J Pharm Pharmacol. 2012 Jul;64(7):919-30. doi: 10.1111/j.2042-7158.2012.01474.x. Epub 2012 Mar 27.
9
Drug formulation and biologic availability.药物制剂与生物利用度。
Semin Drug Treat. 1971 Sep;1(2):148-76.
10
[Evaluation of the physiological availability of drug substances in capsules].
Farmatsiia. 1975 Jan-Feb;24(1):78-82.
Zotero 插件